aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Lycia Therapeutics was founded with the mission to revolutionize the treatment of diseases by targeting and degrading extracellular proteins. The company leverages its proprietary LYTAC (Lysosomal Targeting Chimera) platform to develop innovative therapies aimed at depleting difficult-to-drug targets. Lycia's core focus is on creating first-in-class extracellular protein degraders, addressing unmet medical needs across various therapeutic areas.
Notable affiliates include leading scientists and industry experts who contribute to the company's strategic direction and innovation. Lycia has garnered significant interest from top-tier investors, aiding in its rapid development and growth. The company's groundbreaking work with the LYTAC platform has positioned it as a leader in the field of extracellular protein degradation, promising substantial impact on future therapeutic approaches and patient outcomes.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Protein Degradation
Technology
Biotech
Tags
Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Lycia Therapeutics founded?
Lycia Therapeutics was founded in 2019.
Where is Lycia Therapeutics’s headquarters located?
Lycia Therapeutics’s headquarters is located in San Diego, CA, US.
When was Lycia Therapeutics’s last funding round?
Lycia Therapeutics’s most recent funding round was for $70M (USD) in September 2021.
How many employees does Lycia Therapeutics have?
Lycia Therapeutics has 42 employees as of Feb 5, 2024.
How much has Lycia Therapeutics raised to-date?
As of July 05, 2023, Lycia Therapeutics has raised a total of $120M (USD) since Sep 9, 2021.
Add Comparison
Total Raised to Date
$120M
USD
Last Update Sep 9, 2021
Last Deal Details
$70M
USD
Sep 9, 2021
Series B
Total Employees Over Time
42
As of Feb 2024
Lycia Therapeutics Address
6175 Nancy Ridge Drive
San Diego,
California
92121
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts